North Philadelphia Health Systems

What the SAMHSA Record Shows About North Philadelphia Health Systems

North Philadelphia Health Systems is a substance use treatment operated by a state government entity in Philadelphia, Pennsylvania. The facility's N-SUMHSS record lists 2 primary care modalities (residential, telehealth), which shapes both how treatment is delivered and how intake is scheduled. Medication-Assisted Treatment (MAT) is reported as available, meaning FDA-approved medications such as methadone, buprenorphine, or naltrexone may be combined with counseling for opioid or alcohol use disorder. The full postal address on file is 801 West Girard Avenue, Magnolia Building, 4th Floor, Philadelphia, PA 19122.

On the services side, the facility self-reports 9 distinct service lines, 3 substance or condition categories treated, 11 clinical treatment approaches, and serves 3 specific population groups with 2 languages of care. Those counts give a rough signal of programmatic breadth — a higher number of approaches and populations usually indicates more structured clinical programming rather than a single-modality operation. Payment-wise, the record confirms Medicaid, plus 3 specific payment methods enumerated in the survey.

Use this page as a starting screen, not a final decision. SAMHSA fields are self-reported by the facility and refreshed on a rolling basis, so wait times, bed availability, current insurance contracts, and staff credentials are best confirmed on a direct intake call to (215) 787-2389. This page is a factual directory summary, not medical advice, clinical endorsement, or a guarantee of admission. For any acute crisis or active substance-use emergency, call the SAMHSA National Helpline at 1-800-662-4357 or the 988 Suicide & Crisis Lifeline before visiting any facility.